Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001144204-16-080441

Options or other derivatives

  • Chief Executive Officer acquired 220,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LEDERMAN SETH Chief Executive Officer 2016-02-09 Grant or award · Stock Option +110,000 110,000 D
LEDERMAN SETH Chief Executive Officer 2016-02-09 Grant or award · Stock Option +110,000 110,000 D
Loading xslF345X03/v431264_4.xml…